drug
beremagene geperpavec
Marketedupdated 3mo agoby $KRYS Krystal Biotech, Inc.
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying beremagene geperpavec
News(1)
- J&J pharma leader to retire; Krystal slumps on gene therapy missJennifer Taubert will step down after a lengthy run leading J&J’s pharmaceutical business. Elsewhere, pricing issues hampered what Wall Street analysts view as an otherwise strong gene therapy launch.biopharma_dive · 10d ago
Data sources
last refreshed 18m ago
Found something off?
comments(0)
5-min edit window · permanent after that